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Ebolavirus is responsible for highly lethal hemorrhagic fever. Like all viruses, it must reproduce its various components
and assemble them in cells in order to reproduce infectious virions and perpetuate itself. To generate infectious
Ebolavirus, a viral genome-protein complex called the nucleocapsid (NC) must be produced and transported to the cell
surface, incorporated into virions, and then released from cells. To further our understanding of the Ebolavirus life
cycle, we expressed the various viral proteins in mammalian cells and examined them ultrastructurally and
biochemically. Expression of nucleoprotein alone led to the formation of helical tubes, which likely serve as a core for
the NC. The matrix protein VP40 was found to be critical for transport of NCs to the cell surface and for the
incorporation of NCs into virions, where interaction between nucleoprotein and the matrix protein VP40 is likely
essential for these processes. Examination of virus-infected cells revealed that virions containing NCs mainly emerge
horizontally from the cell surface, whereas empty virions mainly bud vertically, suggesting that horizontal budding is
the major mode of Ebolavirus budding. These data form a foundation for the identification and development of
potential antiviral agents to combat the devastating disease caused by this virus.
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Introduction
Ebolavirus, together with Marburgvirus, comprise the family
Filoviridae in the order Mononegavirales [1,2]. It has a
nonsegmented, negative-sense RNA genome that encodes at
least seven structural proteins [1,3]. These proteins form
ﬁlamentous particles 80 nm in diameter with lipid membrane
derived from host cells. The viral glycoprotein (GP) protrudes
from the surface of the viral envelope, while the matrix
protein VP40 plays a central role in the morphogenesis of the
ﬁlamentous virions [4–7]. Along the central axis of the
ﬁlamentous virion resides a nucleocapsid (NC) of approx-
imately 50 nm in diameter. This viral genomic RNA-protein
complex has an axial channel at its center [8]. The NCs of
Ebolavirus, which represent the principal units of tran-
scription and replication of the viral genome, are thought
to consist of four proteins: the L polymerase protein, VP35,
nucleoprotein (NP), and VP30. Huang et al. [9] showed that
expression of NP, the membrane-associated VP24 protein,
and VP35 results in the formation of structures morpholog-
ically indistinguishable from the NCs observed in Ebolavirus-
infected cells, demonstrating the involvement of VP24 in the
formation of such structures.
In Ebolavirus infection, newly synthesized viral proteins and
genomic RNA in the form of NCs are transported to the
budding site where the viral components assemble to form
virions [7,10–13]. However, many questions regarding assem-
bly of Ebolavirus particles have yet to be answered. How are
NCs formed in the cytoplasm? How are NCs transported to
the cell surface and incorporated into virions? How do the
ﬁlamentous virions bud from the cell surface? In an attempt
to answer these questions, we performed structural and
biochemical assessments of cells transfected with plasmids
expressing various combinations of Ebola viral proteins and
of cells infected with Ebolavirus.
Results/Discussion
Formation of NC-Like Structures
To conﬁrm whether the expression of NP, VP24, and VP35
are sufﬁcient for the formation of NC-like structures [9,14],
we cotransfected 293T cells with various combinations of
plasmids for the expression of the viral proteins (i.e., NP,
VP24, VP30, VP35, and L) and the minigenome RNA, which
consists of a green ﬂuorescent protein gene ﬂanked by 39
leader and 59 trailer sequences. As previously described [9,14],
coexpression of NP, VP24, and VP35 was indispensable for
the formation of NC-like structures (Figures 1A and S1A) that
are morphologically indistinguishable from NCs in virus-
infected cells (Figure 1B), whereas the viral minigenome RNA
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the individual proteins in the formation of the NC-like
structures, we transfected cells with plasmids expressing NP,
VP24, or VP35. When NP was expressed alone, helical tubes,
the diameter of which was almost the same as that of a central
portion of the NCs (approximately 20–25 nm in diameter),
possessing a central channel (approximately 15–20 nm in
diameter), were arranged in a bundle in the cytoplasm (Figure
S1B–S1D). In the cytoplasm of VP35-expressing cells, large
(approximately 8-lm 3 3-lm) electron-dense structures with
small opaque areas (less than 200 nm in diameter) were
observed near the nucleus (Figure S1E). By contrast, in cells
transfected with the VP24 plasmid, numerous, small electron-
dense pleiomorphic aggregates, identiﬁed as VP24 by
immunoelectron microscopy with an anti-VP24 antibody
(unpublished data), were seen scattered throughout the
cytoplasm (Figure S1F).
To understand how NC-like structures are formed, we
coexpressed NP, VP24, and VP35 in different combinations.
On coexpression of VP35 with VP24, we saw a large number
of pleiomorphic particles near the nucleus that were differ-
ent from the VP35- or VP24-induced structures (Figure S1G),
although an interaction between VP35 and VP24 was not
detected by a coimmunoprecipitation assay (unpublished
data). When VP35 was expressed with NP, small pleiomorphic
structures, whose electron density was similar to that of the
VP35-induced structures, were observed at the periphery of
the clusters formed with NP tubes (Figure S1H). By contrast,
when VP24 was expressed with NP, the morphologies of the
Figure 1. Formation of NC-Like Structures upon the Expression of NP,
VP24, and VP35
(A) Expression of NP, VP24, and VP35 produced filamentous and tubular
NC-like structures approximately 50 nm in diameter.
(B) In Ebolavirus-infected cells, a large number of NCs newly synthesized
in the cytoplasm were observed.
(C) When NP, VP24, and VP35 were expressed simultaneously, NC-like
structures were found at the edge of the NP tubes. Bars, 1 lm (A, B, and
C).
DOI: 10.1371/journal.ppat.0020099.g001
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Synopsis
Ebolavirus is a causative agent of a severe, mostly fatal hemorrhagic
fever in humans. Like all viruses, it must reproduce its various
components and assemble them to reproduce progeny virus
particles. However, because Ebolavirus needs special containment
for biosafety, progress in understanding its morphogenesis has been
slow, resulting in no effective therapies currently available for
humans. To further our understanding of the Ebolavirus life cycle,
the authors examined the specific interactions among viral proteins
and the processes of Ebolavirus morphogenesis.
It is demonstrated that nucleoprotein likely serves as a core for the
nucleocapsid (NC) complex, which is critical for replication and
transcription of viral genome. The interaction of nucleoprotein with
matrix protein VP40 is found to be essential for transport of NCs to
the cell surface and for the incorporation of NCs into virions,
resulting in the formation of mature virus particles. Unique among
all viruses to our knowledge, Ebolavirus particles containing NCs
mainly emerge horizontally from the cell surface, whereas the other
viruses bud vertically. These findings form a foundation for the
identification and development of potential antiviral agents to
combat the devastating disease caused by this virus.small pleiomorphic structures formed by VP24 and of the NP
tubes did not change (unpublished data). Finally, when the
three proteins were expressed simultaneously, NC-like
structures approximately 50 nm in diameter were found at
the edge of the clusters of NP tubes (Figure 1C). These results,
together with the previous biochemical studies demonstrat-
ing interactions between NP and VP24 (Ebolavirus) or NP and
VP35 (Ebolavirus and Marburgvirus) [9,15], suggest that NP
helical structures likely serve as the core for the formation of
the NC-like structures, and that VP35 and VP24 contribute to
this process by interacting with NP at the periphery of the NP
clusters.
VP40 Is Critical for the Transport of NC-Like Structures and
for Virion Incorporation
Upon expression of NP, VP35, and VP24, NC-like struc-
tures were not found at the plasma membrane where
Ebolavirus buds off, indicating that the formation and trans-
portation of NCs to the cell surface are separate events and
likely independently regulated. To determine which viral
proteins are required for NC transport to the cell surface, we
expressed the viral proteins involved in the formation of NC-
like structures, other viral proteins (i.e., L, VP30, VP40, and
GP), and the minigenome RNA in 293T cells. When VP40 was
coexpressed with the proteins required for the NC-like
structures (i.e., NP, VP24, and VP35), these structures were
found immediately beneath the plasma membrane (Figure
2A) in an orderly arrangement, even in the absence of other
viral proteins (i.e., L, VP30, and GP) and the minigenome viral
RNA (unpublished data). Furthermore, VP40 proteins were
detected by immunoelectron microscopy near the NC-like
structures underneath the plasma membrane (Figure S2A).
However, without VP40, NC-like structures at the plasma
membrane could not be detected (Figure S2B). These results
indicate that VP40 plays an important role in the transport of
NC-like structures to the cell surface.
Expression of VP40 results in the formation of virus-like
particles (VLPs), which are released from plasmid-transfected
cells [4,5]. To determine whether NC-like structures are
incorporated into VLPs, we examined the VLPs released from
cells expressing NP, VP24, VP35, and VP40 by negative-
staining electron microscopy. Smooth-surfaced, ﬁlamentous
VLPs were found in the supernatants (Figure 2B). In most of
the VLPs, NC-like structures were present along the central
axis (Figure 2C and 2D), as is seen in NCs detected in
authentic Ebola virions [8]. These observations indicate that
VP40 alone is sufﬁcient for NC incorporation into virions
and that the surface membrane GP is not required for this
event, unlike inﬂuenza virus glycoproteins [16].
VLP Budding Is Dependent on Microtubules
To determine which cellular components are involved in
the transport of the NC-like structures to the plasma
membrane, we expressed NP, VP24, VP35, and VP40 in cells
treated with an intracellular vesicular trafﬁcking inhibitor
(monensin), an actin polymerization inhibitor (cytochalasin
D), a microtubule polymerization inhibitor (nocodazole), or a
microtubule depolymerization inhibitor (taxol). Even when
actin polymerization was disturbed by 10 lg/ml cytochalasin
D (the effect of the drug was conﬁrmed by a change in
enhanced yellow ﬂuorescent protein [EYFP-b] actin distribu-
tion visualized by ﬂuorescence microscopy; not shown), the
amounts of VP40 and NP detected in the supernatants of the
drug-treated cells did not differ from those of untreated cells
(Figure 3A), despite a previous report suggesting the involve-
ment of actin in virion formation [17]. When vesicular
transport was inhibited by 5 lM monensin (a condition under
which the transport of the vesicular stomatitis virus glyco-
protein was conﬁrmed to be inhibited [18]; unpublished
data), a signiﬁcant effect on release of VP40 and NP was not
observed (Figure 3A). By contrast, perturbation of the
microtubule structures by either 10 lM nocodazole or 1 lM
taxol (as indicated by changes in EYFP-tubulin distribution;
not shown) led to a reduction in the levels of NP and VP40
detected in the culture supernatants by more than 56% for
NP and more than 57% for VP40 (Figure 3A).
Using electron microscopy we next examined whether
microtubule-perturbating drugs inhibit the transport of NC-
like structures to plasma membrane. In the presence of
nocodazole or taxol, we did not detect an appreciable
difference in the intracellular localization of NC-like struc-
tures, by comparison to localization in the absence of these
drugs (unpublished data). We therefore tested the effect of
these drugs on VLPs produced by VP40 alone. We found that
perturbation of microtubules with these drugs reduced VP40-
induced VLP release into culture media by 62% for
nocodazole and 64% for taxol (Figure 3B). This ﬁnding is
consistent with a recent report that Ebolavirus VP40 directly
associates with microtubules [19]. These data suggest that a
microtubule-dependent pathway may be involved in the
release of VLPs from cells, which likely explains the
concomitant reduction of NC-like structures in the culture
supernatant.
Interaction between NP and VP40 during the Formation
of VP40-Induced VLPs
When VP40 and NP are coexpressed, NP migrates beneath
the plasma membrane [20], and large amounts of NP are
detectable in the supernatant [21]. To make certain that the
NP detected in the supernatant was indeed incorporated into
VLPs and not released as free NP, we performed a ﬂoatation
analysis with the supernatants of cells expressing either NP
alone or NP and VP40. When NP was coexpressed with VP40
(Figure S3A), it was detected in fractions of low sucrose
concentration (i.e., approximately 1.12 g/cm
3, fraction num-
ber 3) and as free protein in fractions of higher sucrose
concentration. However, when NP was expressed alone, it was
not detected in the supernatant of the transfected cells
Figure 2. VP40 Expression Is Essential for the Transport of NC-Like Structures to the Plasma Membrane
(A) A micrograph of the transport of NC-like structures in cells expressing NP, VP24, VP35, and VP40. (A, inset) Enlargement of the boxed area depicting
the cross section of six NC-like structures beneath the plasma membrane.
(B) NC-like structures were incorporated into VLPs. Inside the VLPs, tubular NC-like structures are observed. NC-like structures released from VLPs broken
during sample preparation can also be seen in the same field (arrow).
(C and D) An NC-like structure (indicated by broken lines in D) residing along the central axis of a filamentous VLP. Bars, 2lm (A), 500 nm (B), or 100 nm
(C).
DOI: 10.1371/journal.ppat.0020099.g002
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Ebolavirus Morphogenesis(Figure S3B). These results suggest that NP exists in
membrane-bound form in the supernatant of cells that
express both NP and VP40.
To obtain direct morphologic evidence that NP is
incorporated into VLPs, we used transmission electron
microscopy (TEM) to examine cells coexpressing NP and
VP40. Following coexpression of NP and VP40, we observed
ﬁlamentous VLPs containing NP helical structures (Figure
4A), which were not observed in VLPs produced by the
expression of VP40 alone (Figure 4C). Indeed, helical NP
structures were found even in VLPs that were just about to
bud (Figure 4B, arrows). To demonstrate a direct interaction
between VP40 and NP, we transfected 293T cells with a VP40-
expressing plasmid alone or together with an NP-expressing
plasmid and subjected the cell lysates and supernatants to
immunoprecipitation with appropriate antibodies. VP40
coimmunoprecipitated with NP, and conversely, NP with
VP40, demonstrating the direct interaction between these
two proteins (Figure S4A and S4B). These results strongly
suggest that the interaction between NP and VP40 is
responsible for the incorporation of NCs into virions.
Ebolavirus Buds in Two Distinct Modes
To gain insight into the budding process of Ebolavirus, we
examined Vero E6 cells infected with Ebolavirus by scanning
electron microscopy (SEM) 2 d post-infection. Unlike unin-
fected Vero E6 cells (Figure S5A), most of the Ebolavirus-
infected cells ‘‘rounded up’’ (Figure S5B), most likely because
of GP-mediated downregulation of cellular adhesion mole-
cules, including integrins [22,23]. In these virus-infected cells,
which harbored many virions on their surface, two different
modes of virus budding were observed. Filamentous virions
were released vertically from the cell surface (Figure 5A), as
previously documented for other ﬁlamentous virions [24–26],
but, in addition, many virions emerged horizontally through
the plasma membrane (Figure 5B). In our studies, both types
of budding were rarely found in the same cells. Since
horizontally budding viruses have never been reported
previously, we further studied these horizontally budding
virions by both SEM and TEM. At an early stage of horizontal
budding, an orderly array of ﬁlaments began to emerge
(Figure 5C, 5F, and 5I). As the horizontal budding progressed
further (Figure 5D, 5G, and 5J), the membranes of the pre-
virions were still connected to the cell. The ﬁlamentous Ebola
virions eventually broke off, completing the budding process
(Figure 5E, 5H, and 5K). These results show that ﬁlamentous
Ebola virions do indeed bud from the plasma membrane
horizontally.
Mature Ebola Virions Containing NCs Primarily Bud
Horizontally
To establish the prevalence of these two modes of Ebolavirus
budding, we randomly selected virus-infected cells, 2 d post-
infection, that had rounded up and were producing virions (n
¼ 123) and used SEM to determine what percentage were
covered with horizontally budding virions. More than 80% of
the cells were producing virions horizontally, indicating that
horizontal budding is the dominant mode of Ebolavirus
budding. What determines the mode of Ebolavirus budding?
One possibility is the presence of NCs and their interaction
with the matrix protein VP40. Support for this hypothesis
comes from our previous observation that expression of VP40
produces VLPs that lack NCs [5], and that these VLPs bud
vertically (Figure 6C). For this reason, we examined the NCs
inside particles budding horizontally or vertically. Most of the
horizontally budding virions contained NCs. Empty particles
were rarely found (Figure 6A). By contrast, although some of
the vertically budding virions contained NCs, most were
empty particles and had slightly smaller diameters than the
horizontally budding virions that contained NCs, likely
because of the lack of NCs (Figure 6B). We counted more
than 100 virus particles containing NC (n ¼ 109) in ultrathin
sections to determine the ratio of horizontally budding
virions to vertically budding virions. 98.2% of the virus
particles possessing NC inside the particles emerged hori-
zontally from the cell surface. Therefore, we conclude that
Ebola virions possessing NCs mainly bud horizontally.
Since the matrix proteins of many negative-strand RNA
viruses are known to interact with their NCs during assembly
[27], it is conceivable that the NCs and the matrix proteins of
Ebolavirus affect the budding mode of virions. Because
Ebolavirus NCs synthesized in the cytoplasm are conveyed to
the plasma membrane by a mechanism involving VP40
(Figure 2A), it may be that the empty VLPs induced by
VP40 are released vertically because they did not accumulate
enough NCs in the cytoplasm.
Our ﬁndings, together with previous biochemical data
[9,15], suggest a model for Ebola virion formation (see Figure
7): NP self-assembles to helical tubes. VP35 and VP24 possibly
Figure 3. VLP Budding Is Dependent on Microtubules
10 lM nocodazole (noc), 1 lM taxol (tax), 10 lg/ml cytochalasin D (cytD),
or 5 lM monensin (mon) was added to cells 3 h after they were
transfected with plasmids expressing (A) NP, VP24, VP35, and VP40, or (B)
VP40 alone. At 16 h post-transfection, proteins in the cell lysates and
supernatants were separated by SDS-PAGE and examined by Western
blotting with anti-NP and anti-VP40 antibodies. Following nocodazol or
taxol treatment, the amounts of both VP40 and NP (A) or VP40 (B) in the
supernatants (i.e., efficiency of VLPs budding) were reduced. cont, mock-
treated control.
DOI: 10.1371/journal.ppat.0020099.g003
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Ebolavirus Morphogenesisinteract with NP around the mass of NP tubes, resulting in the
formation of NC-like structures. The NC-like structures are
then transported to the cell surface via a microtubules-
dependent pathway mediated by VP40. Finally, the NCs are
incorporated into virions through an interaction between NP
and VP40 and bud mainly horizontally from the cell surface.
Thus, our study provides morphologic evidence of interac-
tions among viral proteins during the processes of virion
assembly and budding. These results clearly further our
understanding of the Ebolavirus life cycle. More detailed
investigation should provide attractive targets for the
development of antiviral compounds, such as inhibitors of
virion assembly, formation, or budding.
Materials and Methods
Cells and virus. 293T cells and Vero E6 cells were maintained as
described previously [28]. Vero E6 cells were infected with Zaire
ebolavirus at a multiplicity of infection of 0.5. All infectious materials
were handled in the biosafety level 4 facility of the National
Microbiology Laboratory, Public Health Agency of Canada, at the
Canadian Science Center for Human and Animal Health, Winnipeg,
Manitoba, Canada.
Plasmids and cell transfection. All Zaire ebolavirus cDNAs were
cloned separately into the mammalian expression vector pCAGGS/
MCS [29,30]. A plasmid expressing an Ebolavirus minigenome, which
contains a green ﬂuorescent protein (GFP) gene ﬂanked by 39 leader
and 59 trailer sequences was described elsewhere [28,31]. 293T cells
grown in 6-well plates were transfected with plasmids using Trans IT
293 reagent (Mirus Corporation, Madison, Wisconsin, United States).
Chemical reagents. Cytochalasin D, nocodazole, taxol, and mon-
ensin sodium salt were purchased from Sigma-Aldrich (St. Louis,
Missouri, United States). Final concentrations of 10 lM Nocodazole
(noc), 1 lM taxol (tax), 10 lg/ml cytochalasin D (cytD), or 5 lM
monensin (mon) were added to culture media 3 h post-transfection of
plasmids, and samples were harvested 16 h post-transfection.
Western blotting. 293T cells transfected with protein expression
plasmids were lysed in an SDS-PAGE (sodium dodecyl sulfate-
polyacrylamide gel electrophoresis) sample buffer, and separated
on a 4%–20% PAGE Tris-glycine gradient gel (Daiichi Pure
Chemicals Company, Tokyo, Japan). Blots were then incubated with
rabbit anti-NP and anti-VP40 serum, and binding of the primary
antibodies was detected with the Vectastain ABC kit (Vector
Laboratories, Incorporated, Burlingame, California, United States).
Bands were then visualized by immunostaining (HRP-1000, Konica
Figure 4. NP Helices Are Incorporated into VLPs
(A and B) In cells coexpressing NP and VP40, NP helices can be seen in newly released VP40-induced VLPs (A, arrow), as well as in VLPs just about to bud
(B, arrows).
(C) Empty VLPs released from cells expressing VP40 alone. Bars, 100 nm (A and C) or 500 nm (B).
DOI: 10.1371/journal.ppat.0020099.g004
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Ebolavirus MorphogenesisMinolta Holdings, Incorporated, Tokyo, Japan), and their relative
intensities calculated by using Scion Image (http://www.scioncorp.
com).
TEM and SEM. TEM and immuno-TEM were carried out as
described previously [5]. More than 50 transfected cells were
examined for each test sample. For negative staining, the culture
supernatant of 293T cells was stained with 5% uranyl acetate. All
samples described above were examined with a JEM-1200EX electron
microscope at 80 kV. SEM was performed as described previously
[28].
Fluorescence microscopy. To determine the effects of drugs
(nocodazole, taxol, and cytochalasin D) on NC-like structure trans-
port and incorporation into virions, 293T cells were transfected with
0.5 lg of pEYFP-actin expressing enhanced yellow ﬂuorescence
protein, (EYFP)-b actin fusion protein, or pEYFP-tublin expressing
EYFP-a actin fusion protein (Becton Dickinson, Franklin Lakes, New
Jersey, United States) and then treated with the drugs 3 h post-
transfection. At 16 h post-transfection, the EYFP proteins were
visualized with a BZ-8000 ﬂuorescence microscope (Keyence, Osaka,
Japan).
Floatation assay. Supernatants of plasmid-transfected 293T cells
grown in 6-well plates were concentrated to 500 ll with Amicon
Ultra-4 (Millipore, Billerica, Massachusetts, United States) and mixed
with 1.5 ml of 80% sucrose. They were then overlaid with 2 ml of 50%
sucrose and 1.2 ml of 10% sucrose in SW55 centrifuge tubes,
subjected to centrifugation in a Beckman SW55 rotor at 250,000 3 g
at 4 8C for 16 h, and fractionated (0.6 ml/fraction) from the top.
Immunoprecipitation assay. 293T cells were transfected with a
plasmid expressing VP40 alone or together with an NP-expressing
plasmid, and 48 h later lysed in TNE buffer (10 mM Tris-HCl [pH 7.8],
1% NP40, 0.15M NaCl, 1 mM EDTA). Supernatants of similarly
transfected cells were also harvested 48 h post-transfection, concen-
trated by using Amicon Ultra-4 (Millipore), and then lysed in the
same buffer. After clariﬁcation by centrifugation, the supernatants
were incubated with a rabbit anti-NP antibody (1:500 dilution).
Immune complexes were precipitated by incubation with protein G
sepharose beads (New England Biolabs, Incorporated, Beverly,
Massachusetts, United States), which were suspended in the sample
buffer. After removal of the sepharose beads, the samples were
subjected to SDS-PAGE, followed by Western blot analysis with a
rabbit anti-VP40 antibody. For reciprocal immunoprecipitation
assays, cells were transfected with a plasmid for expression of NP
alone or together with a plasmid for expression of FLAG-tagged
VP40, and the assays were performed with cell lysates and the VLPs in
the culture supernatants.
Figure 5. Different Modes of Ebolavirus Budding
(A) Filamentous virions, approximately 80 nm in diameter, budding from the cell surface vertically or (B) horizontally. (C, F, and I, early stage; D, G and J,
intermediate stage; E, H, and K, final stage).
(C–E) The various steps of horizontal budding observed by SEM. Longitudinal (F–H) and transverse (I–K) sections of virions at different stages of
horizontal budding visualized by TEM. Bars, 3 lm (A and B), 200 nm (C–H), or 100 nm (I–K).
DOI: 10.1371/journal.ppat.0020099.g005
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Figure S1. Electron Micrographs of Cells Expressing NP, VP24, and
VP35
(A) Coexpression of NP, VP24, and VP35 resulted in the formation of
NC-like structures.
(B–D) Expression of NP alone produced a mass of helical tubes (C,
dotted line) approximately 20–25 nm in diameter near the nucleus
(Nuc) (B). Transverse sections of the NP helices are seen on the right
(D), while longitudinal sections can be seen on the left (D).
(E) Expression of VP35 alone formed large electron-dense aggregates
(arrow) near the nucleus (nuc).
(F) Expression of VP24 alone resulted in numerous small pleiomor-
phic structures (arrows) near the nucleus (nuc).
(G) Coexpression of VP35 and VP24 produced large structures near
nucleus (nuc) that differed from the aggregates formed by expression
of either VP24 or VP35 alone.
(H) Accumulation of electron-dense aggregates around the mass of
NP tubes (arrows) was observed in the cytoplasm of cells coexpressing
NP and VP35. Bars, 50 nm (A and B), 2 lm (C, E, G, and H), 500 nm
(D), or 1 lm (F).
Found at DOI: 10.1371/journal.ppat.0020099.sg001 (713 KB PDF).
Figure S2. VP40 Is Essential for the Transport of NC-Like Structures
to the Cell Surface
(A) In cells expressing NP, VP24, VP35, and VP40, VP40 was detected
by an anti-VP40 antibody conjugated with 15 nm gold, near to the
NC-like structures (white arrows) located beneath the plasma
membrane.
(B) Upon expression of all viral proteins except VP40 and the
minigenome viral RNA, NC-like structures (arrows) remained in the
cytoplasm. Bars, 100 nm (A) or 1 lm (B).
Found at DOI: 10.1371/journal.ppat.0020099.sg002 (294 KB PDF).
Figure S3. Floatation Analysis of the Supernatants of Cells Expressing
NP Alone or with VP40
(A) Coexpression of NP and VP40 led to the detection of both
proteins in the same fractions of the lower sucrose concentrations
(fraction number 3).
(B) By contrast, when NP was expressed alone, it was not detected in
the supernatant.
Found at DOI: 10.1371/journal.ppat.0020099.sg003 (69 KB PDF).
Figure 7. A Model of Ebola Virion Formation
(A) NP self-assembles to form helical structures.
(B) VP35 and VP24 interact with the helical structures formed by NP,
resulting in the formation of NC-like structures (C).
(D) NC-like structures are transported to the plasma membrane in the
presence of VP40 via a microtubule-dependent pathway.
(E) NC-like structures are incorporated into VLPs through an interaction
between VP40 and NP that results in the production of filamentous
particles budding horizontally from the cell surface.
DOI: 10.1371/journal.ppat.0020099.g007
Figure 6. Virions Showing Two Different Modes of Budding
(A) The majority of the virions is emerging horizontally from the cell
surface and contains nucleocapsids (B), whereas vertically budding
virions appear empty. Insets in (A) and (B) are larger magnifications of
the areas identified in boxes of the main pictures, depicting cross
sections of VLPs. (C) VLPs induced by the expression of VP40 alone bud
vertically and lack NC-like structures. Bars, 400 nm.
DOI: 10.1371/journal.ppat.0020099.g006
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Ebolavirus MorphogenesisFigure S4. Immunoprecipitation Analysis of the Interaction between
VP40 and NP
(A) VP40 was expressed alone (VP40) or together with NP (VP40 þ
NP). Cell lysates and supernatants were immunoprecipitated with an
anti-NP antibody and then subjected to Western blotting with an
anti-VP40 antibody.
(B) NP was expressed alone (NP) or together with FLAG-tagged VP40
(VP40F). Cell lysates and supernatants were immunoprecipitated with
an anti-FLAG antibody and then subjected to Western blotting with
an anti-NP antibody.
Found at DOI: 10.1371/journal.ppat.0020099.sg004 (685 KB PDF).
Figure S5. Morphologic Changes of Vero E6 Cells upon Ebolavirus
Infection
Vero E6 cells, grown on cover slips, were infected with Ebolavirus and
observed by SEM. (A) Control Vero E6 cells and (B) virus-infected
cells 48 h post-infection. Cell rounding occurs only in virus-infected
cells. (B, inset) Enlarged portion of the picture shown by square in (B).
The cell surface is covered with numerous horizontally budding
virions. Bars, 10 lm.
Found at DOI: 10.1371/journal.ppat.0020099.sg005 (1.8 MB PDF).
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